| Literature DB >> 30477255 |
Julian Kopp1, Christoph Slouka2, Daniel Strohmer3, Julian Kager4, Oliver Spadiut5, Christoph Herwig6,7.
Abstract
The Gram-negative bacterium E. coli is the host of choice for producing a multitude of recombinant proteins relevant in the pharmaceutical industry. Generally, cultivation is easy, media are cheap, and a high product titer can be obtained. However, harsh induction procedures combined with the usage of IPTG (isopropyl β-d-1 thiogalactopyranoside) as an inducer are often believed to cause stress reactions, leading to intracellular protein aggregates, which are so known as so-called inclusion bodies (IBs). Downstream applications in bacterial processes cause the bottleneck in overall process performance, as bacteria lack many post-translational modifications, resulting in time and cost-intensive approaches. Especially purification of inclusion bodies is notoriously known for its long processing times and low yields. In this contribution, we present screening strategies for determination of inclusion body bead size in an E. coli-based bioprocess producing exclusively inclusion bodies. Size can be seen as a critical quality attribute (CQA), as changes in inclusion body behavior have a major effect on subsequent downstream processing. A model-based approach was used, aiming to trigger a distinct inclusion body size: Physiological feeding control, using qs,C as a critical process parameter, has a high impact on inclusion body size and could be modelled using a hyperbolic saturation mechanism calculated in form of a cumulated substrate uptake rate. Within this model, the sugar uptake rate of the cells, in the form of the cumulated sugar uptake-value, was simulated and considered being a key performance indicator for determination of the desired size. We want to highlight that the usage of the mentioned screening strategy in combination with a model-based approach will allow tuning of the process towards a certain inclusion body size using a qs based control only. Optimized inclusion body size at the time-point of harvest should stabilize downstream processing and, therefore, increase the overall time-space yield. Furthermore, production of distinct inclusion body size may be interesting for application as a biocatalyst and nanoparticulate material.Entities:
Keywords: E. coli; bioprocess engineering; inclusion body; process control; recombinant proteins; size
Year: 2018 PMID: 30477255 PMCID: PMC6313631 DOI: 10.3390/microorganisms6040116
Source DB: PubMed Journal: Microorganisms ISSN: 2076-2607
Respective sugar concentrations in media composition.
| Phase | Amount of C-source |
|---|---|
| Preculture | 8 g/L |
| Batch-Media | 20 g/L |
| Feed | either 300 g/L or 600 g/L |
Figure 1(a) Inclusion body (IB) beads at time point of harvest (12 h of induction) including measurement bars (white) after homogenization and subsequent washing with ultrapure water; (b) IB bead size at qs,C of 0.4 g/g/h using glycerol as C-source. Late degradation is based on reduction in the viable cell concentration.
Figure 2(a) IB-bead size dependencies on the amount of fed glycerol shown calculated as dSn value (b) dependence of the IB bead diameter when compared between glucose and glycerol.
Fitting results for hyperbolic-fit Equation (3) for IB bead size dependence.
| Fit Parameters | Glucose | Glycerol |
|---|---|---|
| Km [g/g] | 0.33 +/− 0.14 | 0.42 +/− 0.06 |
| IBsize,max [nm] | 605.4 +/− 37 | 638 +/− 17 |
Figure 3(a) Model cultivation with change in the qs,C from 0.5 g/g/h to 0.1 g/g/h at a dSn value of about 4 g/g. The lower qs,C value results in a high viable cell concentration at late induction times; (b) probability density plot of cultivations as a function of induction time.
Figure 4(a) Size modeling including real measured data with standard deviations. Especially early sizes could only be described using the model-based approach; (b) Size-titer correlation for fermentation with feeding strategy implied in Figure 3a.